熱門資訊> 正文
拜耳股份公司非GAAP每股收益为0.94欧元，收入为111.4亿欧元;重申24财年前景
2024-08-06 13:51
- Bayer AG press release (OTCPK:BAYZF): Q2 Non-GAAP EPS of €0.94.
- Revenue of €11.14B (+0.9% Y/Y).
- EBITDA before special items declines to €2.1 billion (– 16.5%), impacted by currency headwinds.
- Free cash flow at €1.3 billion.
- Net operating cash flow in the second quarter of 2024 amounted to €2,410 million (Q2 2023: €484 million).
- Group outlook confirmed: "We confirm our Group outlook for the year 2024 as published in the Annual Report 2023 and the Quarterly Statement for the first quarter of 2024. For the Crop Science Division, we expect currency- and portfolio-adjusted sales growth and the EBITDA margin before special items to come in at the lower end of the projected ranges. For the Pharmaceuticals Division, however, we now anticipate currency- and portfolio-adjusted sales growth of between 0% and 3% (previously: between minus 4% and 0%)."
More on Bayer AG
- Bayer: Small Signs Of Improvement Are Not Enough
- Bayer to seek label expansion for prostate cancer drug after late-stage trial win
- Burning Rock Biotech joins hands with Bayer to expand precision cancer therapies portfolio
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
